Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

DNAPrint Genomics signs research agreement with Beth Israel Deaconess

July 24, 2006

Pharming seeks European approval for rhC1INH in acute HAE

July 21, 2006

Recent patents describe new possible treatment options for endocrine-related disorders

July 21, 2006

Bayer to license BAY-76-7171

July 21, 2006

First subjects complete phase IIb obesity study of AOD-9604

July 21, 2006

Ipsen and Tercica establish worldwide strategic collaboration in endocrinology

July 21, 2006

Solvay seeks E.U. approval of Synordia

July 20, 2006

Roche exercises option to Ipsen's antidiabetic drug BIM-51077

July 20, 2006

Cangene's NDA for rhGH Accretropin accepted for review

July 20, 2006

Transition Therapeutics and Novo Nordisk amend I.N.T. license agreement

July 20, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...